Delivery Order SPE2DB24D2105-SPE2DB25FAQGS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $47,320.66 to AmerisourceBergen Drug Corp for the supply of Dasatinib 100 mg tablets (30-count units). This competitive award, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Dasatinib 100 mg tablets in a 30-count package, with a contract ceiling value of $4,816.96. This non-set-aside, competitively awarded delivery order employs firm fixed pricing and is scheduled for completion by April 25, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $24,781.68 delivery order to AmerisourceBergen Drug Corp for the supply of Dasatinib 100 mg tablets in quantities of 30, with an ultimate completion date of September 5, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child order under AmerisourceBergen's larger contract vehicle with the agency. The pharmaceutical product will be delivered to the contractor's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Dasatinib 100 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $37,364.76, with an ultimate completion date of August 15, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $23,157.77 to AmerisourceBergen Drug Corp for the supply of Dasatinib 80 mg tablets (30-count units) under a firm fixed-price contract type. The order was competitively awarded without set-aside designation and carries an ultimate completion date of September 10, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $9,051.89 to AmerisourceBergen Drug Corp for the supply of Dasatinib 140 mg tablets (30-count units) with a firm fixed price structure. This competitive award, issued on September 23, 2025, with an ultimate completion date of September 24, 2025, represents a single delivery order under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The place of performance is listed as the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $9,193.03 to AmerisourceBergen Drug Corp for Dasatinib 50 mg tablets (60-count supply) on August 11, 2025, with a completion date of August 12, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,744.14 to AmerisourceBergen Drug Corp for the supply of Dasatinib 140 mg tablets (30-count units) on September 23, 2025, with an ultimate completion date of September 24, 2025. The contract employs firm fixed pricing under a non-competitive, non-set-aside delivery order structure. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a $25,721.56 delivery order to AmerisourceBergen Drug Corp for Dasatinib 80 mg tablets in a 30-count supply on September 25, 2025, with completion scheduled for September 26, 2025. This competitive, firm fixed-price contract carries no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through December 2026. The place...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,448.37 to AmerisourceBergen Drug Corp for the supply of Dasatinib 80 mg tablets (30-count units) with an ultimate completion date of August 5, 2025. The contract was competitively awarded with no set-aside designation and utilizes firm fixed pricing. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DB24D2105Indefinite Delivery Contract
- SPE2DB24D2105-SPE2DB25FAQGSDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dasatinib 100 mg tablets (30-count units) under a firm fixed-price contract valued at $33,764.34, with completion targeted for September 26, 2025. This competitively awarded, non-set-aside delivery order represents a continuation of the vendor's role as a critical pharmaceutical supplier to the federal government. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfills this delivery order through its corporate office operations and leverages its established infrastructure to support military and federal healthcare procurement requirements. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDV serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The firm's consistent track record of competitively awarded contracts demonstrates its capability to meet stringent federal procurement standards and supply critical pharmaceutical products across multiple therapeutic domains in support of military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $33.8k | 9/25/25 |